News Releases

Research at UB and Roswell Park that is aimed at developing new tools for clinical and translational science will be highlighted Oct. 21 from 2 - 4 p.m. at the First Annual Clinical and Translational Research Colloquium on Pilot Studies and Novel Technologies.

Research in the field of geography has led to a better understanding of the pros and cons of corporate responsibility initiatives, according to a new paper on the topic by a University at Buffalo geographer, a corporate responsibility expert.

Kathleen A. Parks, senior research scientist at the University at Buffalo's Research Institute on Addictions, who studies women's substance use and associated victimization, recently received a grant from the National Institute on Alcohol Abuse and Alcoholism to continue her research on women's risks for sexual assault associated with heterosexual drinking situations.

The prospect of doing human clinical trials with stem cells to treat diseases like multiple sclerosis may be growing closer, say scientists at the University at Buffalo and the University at Rochester, who have developed a more precise way to isolate stem cells that will make myelin.

A coalition of regional partners has received $9.8 million from the National Science Foundation to expand a promising, teacher-focused initiative that aims to change how science is taught in Buffalo Public Schools. The five-year program, led by the University at Buffalo, Buffalo Public Schools, Buffalo State College and the Buffalo Museum of Science, is called the Interdisciplinary Science and Engineering Partnership (ISEP).

A session on emerging energy companies at this week's Advanced Energy 2011 conference will feature a University at Buffalo inventor: Vladimir Mitin, who is looking to commercialize a new and highly efficient solar cell technology that he developed through his research. The session will take place Thursday (Oct. 13) at 9 a.m. in the Niagara Room of the Hyatt Regency Buffalo at 2 Fountain Plaza in Buffalo, starting with a welcome and introduction from UB Vice President of Research Alex Cartwright.

The Center for the Arts at the University at Buffalo will present Ray Davies on Sunday, Nov. 13, at 7:30 p.m. in the Mainstage Theatre in the Center for the Arts, North Campus.

The University at Buffalo has been awarded funding to conduct important medical research in neuroscience and pediatric pharmacology as part of SUNY REACH, a collaborative research network of SUNY's four academic health centers and the College of Optometry.

The Oct. 12 Martel Distinguished Critic Lecture by French architect Philippe Rahm, to have taken place at 5:30 p.m. in 301 Crosby Hall on the University at Buffalo South Campus, has been postponed and will be rescheduled at a date and time TBA. The lecture is sponsored by the UB School of Architecture and Planning.

A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative diseases. The research on the NMDA (N-methyl-D-aspartate) receptor was published online Oct. 11 in Nature Communications.